Patent 10426790 was granted and assigned to Aldeyra Therapeutics on October, 2019 by the United States Patent and Trademark Office.
The present disclosure provides methods of treating eye allergies and allergic conjunctivitis with cyclodextrin. Ophthalmic compositions of cyclodextrin for topical administration are also provided.